World's Best Scientists 2026 revealed!
Tatsuya Kanto

Tatsuya Kanto

D-Index & Metrics

Immunology

D-Index
60
Citations
11439
World Ranking
3350
National Ranking
134

Best Publications

  • Impaired Allostimulatory Capacity of Peripheral Blood Dendritic Cells Recovered from Hepatitis C Virus-Infected Individuals

    Tatsuya Kanto;Norio Hayashi;Tetsuo Takehara;Tomohide Tatsumi

  • Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma.

    Yoshito Tomimaru;Hidetoshi Eguchi;Hiroaki Nagano;Hiroshi Wada

  • Critical Role of MHC Class I-Related Chain A and B Expression on IFN-α-Stimulated Dendritic Cells in NK Cell Activation: Impairment in Chronic Hepatitis C Virus Infection

    Masahisa Jinushi;Tetsuo Takehara;Tatsuya Kanto;Tomohide Tatsumi

  • Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid.

    Masahisa Jinushi;Tetsuo Takehara;Tomohide Tatsumi;Tatsuya Kanto

  • Negative Regulation of NK Cell Activities by Inhibitory Receptor CD94/NKG2A Leads to Altered NK Cell-Induced Modulation of Dendritic Cell Functions in Chronic Hepatitis C Virus Infection

    Masahisa Jinushi;Tetsuo Takehara;Tomohide Tatsumi;Tatsuya Kanto

  • Reduced Numbers and Impaired Ability of Myeloid and Plasmacytoid Dendritic Cells to Polarize T Helper Cells in Chronic Hepatitis C Virus Infection

    Tatsuya Kanto;Michiyo Inoue;Hideki Miyatake;Aki Sato

  • A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells.

    Young Ik Son;Shin Ichi Egawa;Tomohide Tatsumi;Richard E. Redlinger

  • Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines.

    Takayuki Abe;Yuuki Kaname;Itsuki Hamamoto;Yoshimi Tsuda

  • Autocrine/Paracrine IL-15 That Is Required for Type I IFN-Mediated Dendritic Cell Expression of MHC Class I-Related Chain A and B Is Impaired in Hepatitis C Virus Infection

    Masahisa Jinushi;Tetsuo Takehara;Tomohide Tatsumi;Tatsuya Kanto

  • Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

    Noriyoshi Kuzushita;Norio Hayashi;Toyoki Moribe;Kazuhiro Katayama

  • The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.

    Hayato Hikita;Tetsuo Takehara;Satoshi Shimizu;Takahiro Kodama

  • Buoyant density of hepatitis C virus recovered from infected hosts : two different features in sucrose equilibrium density-gradient centrifugation related to degree of liver inflammation

    Tatsuya Kanto;Norio Hayashi;Tetsuo Takehara;Hideki Hagiwara

  • TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis.

    Tokuhiro Matsubara;Tatsuya Kanto;Shoko Kuroda;Sachiyo Yoshio

  • Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity.

    Tatsuya Kanto;Norio Hayashi

  • Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma

    Tomohide Tatsumi;Tetsuo Takehara;Kazuhiro Katayama;Kiyoshi Mochizuki

  • Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway.

    Hisashi Ishida;Tomohide Tatsumi;Atsushi Hosui;Takatoshi Nawa

  • Ceramide mediates tumor-induced dendritic cell apoptosis.

    Tatsuya Kanto;Pawel Kalinski;Oriana C. Hunter;Michael T. Lotze

  • Human blood dendritic cell antigen 3 (BDCA3)+ dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus

    Sachiyo Yoshio;Tatsuya Kanto;Shoko Kuroda;Tokuhiro Matsubara

  • Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma

    Tomohide Tatsumi;Tetsuo Takehara;Tatsuya Kanto;Takuya Miyagi

  • Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial

    Kiminori Kimura;Akemi Ikoma;Maki Shibakawa;Shinji Shimoda

Frequent Co-Authors

Tetsuo Takehara
Tetsuo Takehara Osaka University
Norio Hayashi
Norio Hayashi Osaka University
Masashi Mizokami
Masashi Mizokami National Center For Global Health and Medicine
Masatsugu Hori
Masatsugu Hori Osaka University
Akinobu Taketomi
Akinobu Taketomi Hokkaido University
Yoshiharu Matsuura
Yoshiharu Matsuura Osaka University
Eiji Miyoshi
Eiji Miyoshi Osaka University
Akihiko Ito
Akihiko Ito Kindai University
Masaki Mori
Masaki Mori Kyushu University
Kohji Moriishi
Kohji Moriishi University of Yamanashi

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Tatsuya Kanto

Recently Published Articles